Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

nov 102016 Capital Markets Day

Genmab will host a Capital Markets Day on November 10, 2016 at the Four Seasons Hotel in New York. The meeting will feature a variety of Genmab speakers who will provide updates on our business including the clinical and pre-clinical pipelines, proprietary next generation antibody technologies and R&D capabilities. Click here for more information and to register for the event. This meeting will be webcast live and details on how to join the webcast will be available on

BeakersOur Technologies Explained

Visit to learn about Genmab's innovative proprietary technologies; the DuoBody® and HexaBody® platforms.


Lab tourVirtual Lab Tour

Watch our new virtual lab tour to learn more about Genmab’s research and development capabilities and our proprietary DuoBody® and HexaBody® technologies.